← Back to Search

Macrolide Antibiotic

1 for Sinus Infection

Phase 4
Waitlist Available
Led By Jerome J Schentag, Pharm.D.
Research Sponsored by CPL Associates
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 42 days
Awards & highlights

Summary

The purpose of this study is to measure the speed of microbial eradication due to azithromycin or telithromycin in acute maxillary sinusitis (AMS).

Eligible Conditions
  • Sinus Infection

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~42 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 42 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Bacterial resistance or selection
Secondary outcome measures
Bacteriologic outcome

Trial Design

2Treatment groups
Active Control
Group I: 1Active Control1 Intervention
Subjects assigned Azithromycin
Group II: 2Active Control1 Intervention
Subjects assigned Telithromycin

Find a Location

Who is running the clinical trial?

CPL AssociatesLead Sponsor
8 Previous Clinical Trials
602 Total Patients Enrolled
SanofiIndustry Sponsor
2,173 Previous Clinical Trials
3,516,298 Total Patients Enrolled
Jerome J Schentag, Pharm.D.Principal InvestigatorState University of NY at Buffalo
3 Previous Clinical Trials
230 Total Patients Enrolled
~10 spots leftby Jul 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top